Management of chronic asthma.
The treatment of asthma is changing to reflect the importance of inflammation in the disease pathogenesis. Medicines that alter the inflammatory response are the cornerstone of therapy for patients with persistent symptoms. Bronchodilators are important in acute care, but in chronic illness they are adjuvant therapy. Patient education is essential for successful outcome.
Stempel
D A
DA
Department of Pediatrics, University of Washington, Seattle.
Szefler
S J
SJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001249:Asthma / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D017835:Nedocromil; D015363:Quinolones / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D015363:Quinolones; D017835:Nedocromil; D004205:Cromolyn Sodium